MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Eagle Pharmaceuticals Company Profile (NASDAQ:EGRX)

Consensus Ratings for Eagle Pharmaceuticals (NASDAQ:EGRX) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $89.60 (91.74% upside)

Analysts' Ratings History for Eagle Pharmaceuticals (NASDAQ:EGRX)
Show:
DateFirmActionRatingPrice TargetActions
5/10/2016RBC CapitalLower Price TargetOutperform$94.00 -> $78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2016MizuhoReiterated RatingBuy$71.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2016Piper JaffrayReiterated RatingOverweight$98.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/31/2016William BlairReiterated RatingOutperform$109.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2015Cantor FitzgeraldReiterated RatingBuy$95.00 -> $92.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha